Press Releases
Debiopharm Launches Expansion of WEE1 Inhibitor Monotherapy Research in Gynecological Cancers and Other Biomarker-Driven Solid Tumors
Strategikon Closes Series A1 Funding Round to Modernize Clinical Trials Business Operations Worldwide
Challenge pour la Qualité de vie du patient 2024, l’appel à projets est ouvert
TransCode Therapeutics and Debiopharm Announce Collaboration to Develop Targeted Nucleic Acid Therapeutics for Cancer
Debiopharm and ThinkingNodeLife.ai Forge Strategic Partnership to Propel Cancer Drug Development
MedaSystems Secures Additional Funding from Debiopharm Innovation Fund to Accelerate Global Access to Pre-approval Treatment
Debiopharm Extends SunRock Biopharma Partnership for Antibody-Drug Conjugates Targeting HER3 in EGFR Mutated Cancers
Debiopharm and Repare Therapeutics Partner to Explore the Synthetic Lethal Combination of PKMYT1 and WEE1 Inhibition in Cancer